Histopathology Reporting and MDT

Concepts

• taunton
• pathology services
• digital histopathology reporting
• histopathology reporting
• mdt
• provision of digital histopathology reporting
• (trephine) reporting
• reporting
• histopathology
• c.the lifetime value

Location

Taunton

Description

Provision of Digital Histopathology Reporting and MDT. Lymphoma second opinion and Bone Marrow (Trephine) reporting.

Total Quantity or Scope

Lymphoma second opinion and Bone Marrow (Trephine) reporting.The Authority is intending to award the contract to an existing provider following the direct award process C.The lifetime value of this contract is expected to be £128,208.00The contract dates are 14 August 2025 to 13 August 2026 with the option to extend for 12 months.

Award Detail

Award Criteria

CPV Codes

• 85111800 - Pathology services

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 13 August 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Other Information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.The decision makers were: Deputy Service Group Director - Clinical Support & Cancer ServicesNo conflicts of interest were declared among decision makers.The key criteria were weighted as follows:40% quality and Innovation15% Value20% Integration, Collaboration and Service Sustainability15% Improving access, reducing health inequalities and facilitating choice10% Social valueQuality is the most important aspect of this service as the level of expertise is extremely hard to find and essential for providing second opinions on complex cancer patients. Integration and collaboration is also essential. The rationale for choosing the provider with reference to the key criteria:The existing suppliers are experienced services providers with a proven track record, and they are highly likely to be able to satisfy the new contract to a sufficient standard.